Xerostomia, commonly called dry mouth, is a prevalent condition that adversely affects oral health and quality of life. It results from inadequate salivary secretion and produces symptoms such as dysphagia, dysarthria, and an increased risk of dental caries and oral infections. Aquoral Spray uses a proprietary lipid-based formulation intended to reduce these symptoms. This article examines the pathophysiology of xerostomia, Aquoral’s lipid technology, treatment approaches, and recommended usage and safety considerations.
What is dry mouth and how does it affect oral mucosa hydration?
Medically defined, xerostomia means a persistent sensation of oral dryness due to diminished salivary flow. This deficit impairs oral functions including taste, chewing and swallowing, and increases susceptibility to dental decay and periodontal disease. The oral mucosa depends on adequate moisture to preserve epithelial integrity, barrier function and tissue homeostasis.
What causes xerostomia and how does it affect oral health?
Multiple causes contribute to xerostomia, including medications, systemic diseases and behavioural factors. Principal contributors include:
- Medications: Many medicines, including over-the-counter ones, notably antihistamines, antidepressants and diuretics, have drying effects. See medications that cause dry mouth.
- Medical conditions: Systemic disorders such as diabetes mellitus, Sjögren’s and other autoimmune diseases may impair salivary gland function.
- Lifestyle factors: Tobacco use, alcohol consumption and inadequate hydration can worsen oral dryness.
The consequences of xerostomia include increased plaque accumulation, halitosis and a higher incidence of oral infections. Identifying causative factors guides targeted management.
How does Aquoral Spray’s lipid-based oral barrier protect the oral mucosa?
Aquoral Spray uses a lipid-based delivery system designed to form a protective film on the oral mucosa. This lipid barrier reduces transepithelial water loss and maintains mucosal hydration, easing the symptoms of dry mouth.
Published studies show that lipid-based formulations can provide symptomatic relief in xerostomia.
Mucoadhesive lipid-based tablets for dry mouth relief
The aim of this study was to evaluate a mucoadhesive lipid-based bioerodable tablet as a novel device to decrease signs and symptoms associated with mouth dryness.
Evaluation of a mucoadhesive lipid-based bioerodable tablet compared with Biotène mouthwash for dry mouth relief–a pilot study., B Mizrahi, 2010
What is the mechanism of action of the lipid technology in Aquoral Spray?
Aquoral’s lipid components assemble into a coherent film on the mucosal surface. This semi-occlusive film limits evaporative water loss and protects the epithelium from chemical and microbial irritants. The lipid layer mimics several protective roles of natural saliva, producing symptomatic relief and improved mucosal comfort.
Additional research highlights the role of advanced lipid carriers in mucosal protection and targeted delivery.
Lipid-based nanoparticles for enhanced oral mucosal drug delivery
Research has focused on strategies such as site-specific mucoadhesion, stimuli-responsive release, and advanced carrier engineering to increase residence time and mucosal penetration.
Topical Drug Delivery in Oral Mucosal Diseases: Challenges, Carriers, and Innovations: A Comprehensive Review, 2025
How does restoring the lipid layer provide long-lasting hydration?
Restoring the mucosal lipid layer is key to sustained oral hydration. By supplementing lipids that are lacking in xerostomic states, Aquoral Spray helps maintain mucosal moisture for a longer time. Users often report noticeable improvement and better oral function after use.
Which dry mouth treatments does Aquoral Spray complement or replace?
Aquoral Spray can be used on its own or alongside existing dry mouth products, offering a lipid-based approach that differs from traditional methods.
How does Aquoral Spray compare to artificial saliva and other hydration methods?
Compared to conventional artificial saliva substitutes, especially water-based formulations that provide only temporary moisture, Aquoral’s lipid-based matrix is designed to offer longer-lasting hydration and mucosal protection. This may make it a better choice for people needing sustained symptom control.
Evaluations of artificial saliva substitutes often find better performance among lipid-containing products.
Lipid-based products as artificial saliva substitutes
Hydration comparable to natural saliva is achievable with mucin and/or lipid based product. Since it is not possible to control shear rate, it is only possible to classify the evaluated saliva substitutes in two different groups.
Artificial saliva substitutes evaluation: The role of some chemical-physical properties, 2018
What are the condition-specific benefits of Aquoral Spray?
Certain groups, including people undergoing head and neck radiotherapy and those with Sjögren’s, may benefit especially from Aquoral Spray. In radiation-induced xerostomia, the product can reduce dryness symptoms; similarly, people with autoimmune salivary gland dysfunction may experience improved mucosal lubrication and comfort.
Usage guidelines and safety considerations for Aquoral Spray
Following the directions on the package gets the most from Aquoral Spray and ensures safe use.
How should I apply Aquoral Spray for the best oral mucosa protection?
Apply Aquoral Spray directly onto the oral mucosa as needed. Using it before meals and at bedtime is recommended to keep the mucosa hydrated during times of increased oral demand and overnight.
What is Aquoral Spray’s safety profile?
Clinical studies have reported a good safety profile with no significant adverse events in healthy adult groups. People with known allergies to any ingredient should talk to a health professional before use.
Also, for people who have dysphagia related to xerostomia, Aquoral Spray may help improve comfort and ease of eating and drinking.
This article is general information and does not replace advice from your health professional. Content adapted for Canada; pending review.